Zionsville, IN, United States of America

Emily Suzanne Murzinski

This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignee: Eli Lilly and Company. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Emily Suzanne Murzinski: Innovator in Pharmaceutical Processes

Introduction

Emily Suzanne Murzinski is a notable inventor based in Zionsville, Indiana. She has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for preparing tirzepatide. Her work is essential in advancing medical treatments and improving patient outcomes.

Latest Patents

Emily holds 1 patent for her invention titled "Processes and intermediates for preparing tirzepatide." This patent provides new intermediates and processes that are useful in the manufacture of tirzepatide, or a pharmaceutically acceptable salt thereof. Her innovative approach has the potential to enhance the efficiency of drug production.

Career Highlights

Emily is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. Her role involves research and development, where she applies her expertise to create effective pharmaceutical solutions. Her contributions are vital to the company's mission of improving health through innovative medicines.

Collaborations

Emily has collaborated with talented coworkers, including Michael E. Kopach and Rachel Nicole Richey. These partnerships foster a creative environment that encourages the exchange of ideas and enhances the development of new pharmaceutical processes.

Conclusion

Emily Suzanne Murzinski is a pioneering inventor whose work in pharmaceutical processes is making a significant impact in the industry. Her dedication to innovation and collaboration continues to drive advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…